DOCSLIB.ORG

Sistema and VTB to Create a Major Pharmaceuticals Holding The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sistema and VTB to Create a Major Pharmaceuticals Holding The Correction: Sistema and VTB to create a major pharmaceuticals holding The following amendment has been made to the announcement “Sistema and VTB to create a major pharmaceuticals holding” released on 28 December 2018 at 06:54 GMT The sentence “Sistema invested a total of RUB 1.83 billion in the acquisition of OBL Pharm, giving Sistema an effective stake in OBL Pharm of 11.7%” should read “Sistema invested a total of RUB 1.83 billion in the acquisition of OBL Pharm, giving Sistema an effective stake in OBL Pharm of 13%”. Aforesaid amendment is incorporated in order to correct a technical typo that was present in the announcement released on 28 December 2018 at 06:54 GMT. All other details of the announcement released on 28 December 2018 at 06:54 GMT remain unchanged. The full amended text is shown below. Moscow, Russia - 28 December 2018 – Sistema PJSFC (“Sistema”) (LSE: SSA, MOEX: AFKS), a publicly traded diversified Russian holding company, announces it has acquired an equity interest in JSC Pharmaceutical Enterprise Obolenskoe (“OBL Pharm”), a leading Russian pharmaceutical company. The stake was acquired jointly with VTB Bank (“VTB”) and management of OBL Pharm from Alvansa Ltd, which is majority-owned by Gazprombank and UFG Private Equity. Sistema invested a total of RUB 1.83 billion in the acquisition of OBL Pharm, giving Sistema an effective stake in OBL Pharm of 13%.The investment consortium – consisting of Sistema, VTB and members of the OBL Pharm management team – collectively acquired 95.14% of OBL Pharm for a total investment of RUB 15.5 billion. The partners made their investments through a joint holding company, Ristango Holding Limited, and have signed a shareholder agreement securing rights of all of the investors to participate in management of the business. Sistema and VTB have also signed an agreement whereby Sistema will acquire VTB’s stake in Ristango Holding Limited within three years of the initial transaction. The Russian Direct Investment Fund (“RDIF”) and its co-investors have reached an agreement with Sistema to consider participating in the transaction in early 2019 following additional study of the transaction terms and approval of the transaction terms by an RDIF-led consortium of investors. The transaction aims to create a leading Russian pharmaceuticals group following the merger of OBL Pharm with JSC Binnopharm (“Binnopharm”), a Sistema portfolio company. OBL Pharm and Binnopharm will be combined to create a unified company that is a top-10 Russian pharmaceutical company in the non-statesector with a diversified portfolio of over 200 products. Products that are leaders in their segments include vein tonic Venarus, the probiotic Maxilac and the liver protectant Urdoxa. The combined company will operate four pharmaceutical production sites in Moscow and the Moscow region, and will be established in the first half of 2019. Andrey Dubovskov, Sistema President and CEO, said: “The acquisition of a stake in OBL Pharm creates a unique opportunity for Sistema and its partners to establish a leading player in Russia’s growing pharmaceuticals market by leveraging synergies with our portfolio company Binnopharm through joint use of production capacities, marketing and sales networks, and R&D capabilities. Binnopharm is a full-cycle biopharmaceutical company with its own in-house R&D division and modern production facilities. OBL Pharm is a fast-growing company that has an experienced management team and a well-developed portfolio of branded products. The companies also have complementary business models and assets, which creates further opportunities for a significant increase in the shareholder value of our pharmaceuticals business.” Yuri Soloviev, First Deputy President and Chairman of VTB Bank Management Board, said: “As one of the leading companies in the highly prospective Russian pharmaceutical market, OBL Pharm has a strong track record in increasing its business operations and is pursuing ambitious development plans. The merger with Binnopharm will serve as a new impetus for further expansion. We strongly believe that VTB Group’s broad experience and financial resources will significantly enhance the company’s shareholder value and ensure attractive returns for both existing shareholders and potential new investors.” *** OBL Pharm is a Russian pharmaceutical company engaged in the development, production and marketing of modern, high-quality pharmaceuticals in accordance with GMP and ISO standards. The Company was founded in 1994 and since 2013 has been part of Alvansa Group, in which Gazprombank and the UFG Private Equity Investment Fund are shareholders. The company specialises in the production of solid dosage form products, manufacturing more than 150 prescription and over-the-counter pharmaceuticals for gastroenterological, cardiologic, phlebologic and neurologic diseases, as well as for the treatment of pain, insomnia, men’s health and more. The Company’s portfolio includes both innovative and generic pharmaceuticals. Its production capacities include an existing facility in Obolensk, Moscow region with capacity to produce 330 tonnes of tablet mass annually. In 2019, the Company plans to launch another facility in Obolensk with total annual capacity of 900 tonnes of tablet mass. JSC Binnopharm is one of Russia's largest full-cycle biopharmaceutical companies with an in-house R&D division. The company produces and develops new medications in several treatment groups including hepatitis B vaccine, interferons and erythropoetins, a line of pulmonology and neurology drugs, infusion solutions, and anti-viral and immunomodulating drugs. Binnopharm operates two production facilities: the Binnopharm production site in Zelenograd administrative district of Moscow and the Alium facility in Krasnogorsk district of the Moscow region. Its plants produce six types of dosage forms: ampoules, syringes, aerosols, pills, capsules and solutions. Binnopharm has over 20 different products in its portfolio. Another 40 drugs are currently in development or registration. *** For further information, please visit www.sistema.com or contact: Investor Relations Public Relations Nikolai Minashin Sergey Kopytov Tel: +7 (495) 730 66 00 Tel.: +7 (495) 228 15 32 [email protected] [email protected] This announcement contains inside information. Full name and position of person making the announcement – Nikolay Minashin, Director, Investor Relations Sistema PJSFC is a publicly traded diversified Russian holding company serving over 150 million customers in such sectors as telecommunications, retail, paper and packaging, agriculture, high technology, banking, real estate, pharmaceuticals, tourism and healthcare services. The company was founded in 1993. Its revenue in 2017 reached RUB 704.6 billion; its total assets equalled RUB 1.1 trillion as of 31 December 2017. Sistema's global depositary receipts are listed under the symbol “SSA” on the London Stock Exchange. Sistema’s ordinary shares are listed under the “AFKS” ticker on the Moscow Exchange. Website: www.sistema.ru *** .
Load more

Recommended publications
  • Annual Report
    2014 ANNUAL REPORT TABLE OF CONTENTS Sistema today 2 Corporate governance system 91 History timeline 4 Corporate governance principles 92 Company structure 8 General Meeting of shareholders 94 President’s speech 10 Board of Directors 96 Strategic Review 11 Commitees of the Board of Directors 99 Strategy 12 President and the Management Board 101 Sistema’s financial results 20 Internal control and audit 103 Shareholder capital and securities 24 Development of the corporate 104 governance system in 2014 Our investments 27 Remuneration 105 MTS 28 Risks 106 Detsky Mir 34 Sustainable development 113 Medsi Group 38 Responsible investor 114 Lesinvest Group (Segezha) 44 Social investment 115 Bashkirian Power Grid Company 52 Education, science, innovation 115 RTI 56 Culture 117 SG-trans 60 Environment 119 MTS Bank 64 Society 121 RZ Agro Holding 68 Appendices 124 Targin 72 Binnopharm 76 Real estate 80 Sistema Shyam TeleServices 84 Sistema Mass Media 88 1 SISTEMA TODAY Established in 1993, today Sistema including telecommunications, companies. Sistema’s competencies is a large private investor operating utilities, retail, high tech, pulp and focus on improvement of the in the real sector of the Russian paper, pharmaceuticals, healthcare, operational efficiency of acquired economy. Sistema’s investment railway transportation, agriculture, assets through restructuring and portfolio comprises stakes in finance, mass media, tourism, attracting industry partners to predominantly Russian companies etc. Sistema is the controlling enhance expertise and reduce
    [Show full text]
  • Russian Withholding Tax Refund
    Russian withholding tax refund Tax & Legal If you or your clients invested in Russian securities and are entitled to a substantial dividend or interest income, there is a chance that you overpaid your taxes and may qualify for a tax refund © 2018 Deloitte Consulting LLC Background Investors may apply a According to the The Russian The tax refund reduced tax rate for Russian tax withholding tax rate is practice in Russia is their interest and/or authorities, they are set at 15% on not well-developed: dividend income, ready to reimburse dividends and 20 the tax legislation depending on the overpaid taxes, if a percent on interest. does not provide for a conditions set by the full package of Effective from 1 specific list of Russian Tax Code or documents confirming January 2014, the documents to be applicable Double Tax the income payment duties of the tax collected and Treaties. Calculations chain and the agent for WHT requirements to be of a standard Russian investor’s rights to purposes were met. For these rate or the standard the income is transferred to the reasons, the process reduced Double Tax submitted. local Russian can be lengthy and Treaty rate, as well as custodian or, in a sometimes fruitless. submission of claims limited number of However, the trend is on tax can be cases, to the reassuring: the refunded, should be fiduciary, broker or number of successful made by investors issuer. refund claims and themselves within positive court three calendar years, decisions is growing. following the year in which it was withheld.
    [Show full text]
  • CAPITAL MARKETS DAY ______FRIDAY, 30 Th MAY at ONE GREAT GEORGE STREET, LONDON
    CAPITAL MARKETS DAY ____________________________________________________________________________ FRIDAY, 30 th MAY AT ONE GREAT GEORGE STREET, LONDON Sistema (LSE: SSA), the largest diversified corporation in Russia and the CIS, is pleased to invite you to the Capital Markets Day, which will be held at the One Great George Street, Westminster, London SW1P 3AA, on Friday 30 th May, 2008. The conference will comprise presentations on a range of strategic, operational and financial aspects of the Group’s businesses, as well as a number of group and one-on-one meetings with the management of Sistema and its public and non-public businesses. Registration will take place at the One Great George Street, Westminster, London SW1P 3AA, starting from 8:30am. The conference will commence at 9:00am followed by lunch, group and one-on-one meetings from 2:00pm till 7:00pm. The detailed schedule for the day is attached. To register for the event by email to: [email protected] . You may also register by filling out the information below and returning it by fax to +44 (0)207 321 5020 or contact Shared Value on +44 (0)20 7321 5010 for further details. NAME: COMPANY: FUNCTION: SECTOR / COVERAGE: MOBILE PHONE: EMAIL: Yes, I will participate in the Capital Markets Day in London on Friday 30 th May, 2008 I am unable to attend the Capital Markets Day Please remove my name from the Sistema mailing list I would like to participate in group meetings with * If you would like to participate in group meetings, please provide the name of the company you would like to meet: _____________________________________________________________________________ *Sistema may not be able to guarantee a meeting slot as availability is subject to demand Sistema is the largest public diversified corporation in Russia and the CIS, which manages fast growing companies operating in the consumer services sector and has over 80 million customers.
    [Show full text]
  • Deal Drivers Russia
    February 2010 Deal Drivers Russia A survey and review of Russian corporate finance activity Contents Introduction 1 01 M&A Review 2 Overall deal trends 3 Domestic M&A trends 6 Cross-border M&A trends 8 Private equity 11 Acquisition finance 13 Valuations 14 02 Industries 15 Automotive 16 Energy 18 Financial Services 20 Consumer & Retail 22 Industrial Markets 24 Life Sciences 26 Mining 28 Technology, Media & Telecommunications 30 03 Survey Analysis 32 Introduction Prediction may be fast going out of fashion. At the end of 2008, CMS commissioned mergermarket to interview 100 Russian M&A and corporate decision makers to find out what they thought about the situation at the time and what their views on the future were. Falling commodity prices were viewed as the biggest threat, the Financial Services sector was expected to deliver the greatest growth for M&A activity and the bulk of inward investment was expected from Asia. The research revealed that two thirds of the respondents expected the overall level of M&A activity to increase over the course of 2009, with only one third predicting a fall. That third of respondents was right and, in general, the majority got it wrong or very wrong. The survey did get some things right – the predominance of Who knows? What’s the point? We consider the point to be the domestic players, the increase of non-money deals, the in the detail. Our survey looks at the market in 2009 sector number of transactions against a restructuring background, by sector – what was ‘in’ and what was ‘out’.
    [Show full text]
  • Russian Ecm November 6, 2006
    1 Russian ecm November 6, 2006 1. Investment banks index wars 2. 35 companies will raise $19bn in 2007, Deutsche Bank 3. RTS to launch a Russian NASDAQ 4. Market players to be licensed 5. Gazprombank finally to sell off media, petrochemical assets in IPO 6. Owner of the Chelyabinsk zinc plant (CZP) will sell 3% of their shares 7. Chemical firm share price collapses after dilutive share issue 8. Dymov Sausage to IPO 9. Eastern Property Holdigns increases capital by $125m 10. Far Eastern Sea Shipping Company will IPO 11. Mosenergo places in favour of Gazprom 12. OGK-5 sale a big success 13. Pharmaceutical producer to IPO 14. Pipemaker TMK IPOs 15. Russian commodity exchange plans to launch wheat futures 16. Severstal sets IPO price 17. Sistema-Hals IPO price range set 18. Uralkaliy decreases 9-month dividends by a third following flood 19. Uranium company to IPO 20. WBD owners sell small stake Investment banks index wars Monday, November 6, 2006 A veritable war of indexes is breaking out as Two of Russia's top investment banks launched new indexes, better to track Russia's increasingly sophisticated growth, that will compete with the proliferating number of indexes tracking Russia. Renaissance Capital has teamed up with emerging market gurus Morgan Stanley that puts together the widely quoted MSCI index - a benchmark for emerging market stock market preformace - to produce the MSCI http://businessneweurope.eu 2 Renaissance Index of TOP Liquid Russian Stocks (the MSCI Rencap Index, for short). Likewise, Troika Dialog launched a third tier index that tracks 50 companies that are on the up and up but currently fall below all the investment bank's radar screens.
    [Show full text]
  • US Sanctions on Russia
    U.S. Sanctions on Russia Updated January 17, 2020 Congressional Research Service https://crsreports.congress.gov R45415 SUMMARY R45415 U.S. Sanctions on Russia January 17, 2020 Sanctions are a central element of U.S. policy to counter and deter malign Russian behavior. The United States has imposed sanctions on Russia mainly in response to Russia’s 2014 invasion of Cory Welt, Coordinator Ukraine, to reverse and deter further Russian aggression in Ukraine, and to deter Russian Specialist in European aggression against other countries. The United States also has imposed sanctions on Russia in Affairs response to (and to deter) election interference and other malicious cyber-enabled activities, human rights abuses, the use of a chemical weapon, weapons proliferation, illicit trade with North Korea, and support to Syria and Venezuela. Most Members of Congress support a robust Kristin Archick Specialist in European use of sanctions amid concerns about Russia’s international behavior and geostrategic intentions. Affairs Sanctions related to Russia’s invasion of Ukraine are based mainly on four executive orders (EOs) that President Obama issued in 2014. That year, Congress also passed and President Rebecca M. Nelson Obama signed into law two acts establishing sanctions in response to Russia’s invasion of Specialist in International Ukraine: the Support for the Sovereignty, Integrity, Democracy, and Economic Stability of Trade and Finance Ukraine Act of 2014 (SSIDES; P.L. 113-95/H.R. 4152) and the Ukraine Freedom Support Act of 2014 (UFSA; P.L. 113-272/H.R. 5859). Dianne E. Rennack Specialist in Foreign Policy In 2017, Congress passed and President Trump signed into law the Countering Russian Influence Legislation in Europe and Eurasia Act of 2017 (CRIEEA; P.L.
    [Show full text]
  • Investment from Russia Stabilizes After the Global Crisis 1
    Institute of World Economy and International Relations (IMEMO) of Russian Academy of Sciences Investment from Russia stabilizes after the global crisis 1 Report dated June 23, 2011 EMBARGO: The contents of this report must not be quoted or summarized in the print, broadcast or electronic media before June 23, 2011, 3:00 p.m. Moscow; 11 a.m. GMT; and 7 a.m. New York. Moscow and New York, June 23, 2011 : The Institute of World Economy and International Relations (IMEMO) of the Russian Academy of Sciences, Moscow, and the Vale Columbia Center on Sustainable International Investment (VCC), a joint undertaking of the Columbia Law School and the Earth Institute at Columbia University in New York, are releasing the results of their second joint survey of Russian outward investors today 2. The survey is part of a long-term study of the rapid global expansion of multinational enterprises (MNEs) from emerging markets. The present survey, conducted at the beginning of 2011, covers the period 2007-2009. Highlights Despite the global crisis of the last few years, Russia has remained one of the leading outward investors in the world. The foreign assets of Russian MNEs have grown rapidly and only China and Mexico are further ahead among emerging markets. As the results of our survey show, several non- financial 3 Russian MNEs are significant actors in the world economy. The foreign assets of the 20 leading non-financial MNEs were about USD 107 billion at the end of 2009 (table 1). Their foreign sales 4 were USD 198 billion and they had more than 200,000 employees abroad.
    [Show full text]
  • Dmitri V. Kovalenko
    Dmitri V. Kovalenko Partner, Moscow Mergers and Acquisitions; Private Equity; Capital Markets Dmitri Kovalenko is co-head of the Moscow office and represents international and Russian clients on a broad range of mergers and acquisitions, private equity and joint venture transac- tions in Russia and other countries covering various industries and sectors. Mr. Kovalenko has practiced law in Skadden’s Moscow, Chicago and Paris offices since 1994. He is ranked in the top tier for Russia M&A and Russia capital markets work by Chambers Global and Chambers Europe, as well as for private equity in Russia by Chambers Europe. Mr. Kovalenko also was named as the 2021 Mergers and Acquisitions Lawyer of the Year and the 2020 Capital Markets Lawyer of the Year by The Best Lawyers in Russia, and was listed in the publication’s Global Business Edition. Additionally, he is listed as a leading individual in IFLR1000 and Who’s Who Legal, as well as repeatedly in The Legal 500 EMEA as a member of its Commercial, Corporate and M&A: Moscow Hall of Fame. T: 7.495.797.4600 F: 7.495.797.4601 His M&A and private equity experience has included advising: [email protected] - Mercury Retail Group in its US$1.2 billion sale of JSC Dixy Group to PJSC Magnit; - Horvik Limited in relation to its preconditional mandatory offer to acquire Trans-Siberian Gold Education plc, an AIM-quoted gold producer; LL.M. (with honors), Northwestern - Kismet Acquisition One, a special purpose acquisition company, in its US$1.9 billion initial University School of Law, Chicago, merger with Nexters Global Limited, the first-ever de-SPAC transaction involving a Russian USA, 1996 company.
    [Show full text]
  • Annual Report
    Annual Report 2018 About the Company Financial Performance Key Asset Results Corporate Governance Social Responsibility 1 SISTEMA Contents ABOUT THE COMPANY 2 CORPORATE GOVERNANCE 82 Profile of Sistema 4 Sistema’s Corporate Governance Principles 84 Investment Portfolio 6 Sistema’s Corporate Governance Structure 85 CEO’s Statement 8 General Meeting of Shareholders 86 Key Events of 2018 10 Board of Directors 88 ONE OF THE LARGEST Mission and Strategy 14 Committees of the Board of Directors 92 FINANCIAL PERFORMANCE 16 President 94 Financial Performance in 2018 18 Management Board 95 PRIVATE INVESTORS Shareholders’ Equity 22 Committees Reporting to the President 96 and the Management Board Report on Dividends 24 Specific Characteristics of Risk Management, Sistema’s Credit Ratings 25 Internal Control and Internal Audit Systems 98 INTO RUSSIA’S KEY ASSET RESULTS 26 Development of the Corporate Governance System in 2018 100 MTS 28 Remuneration Policy 102 Detsky Mir 32 CONTEMPORARY Risks 104 Segezha Group 36 SOCIAL RESPONSIBILITY 110 Medsi 42 ESG and Corporate Responsibility Principles 112 ECONOMY Agroholding “STEPPE” 49 Contribution to Socio-Economic Development 113 Real Estate Assets 54 Social Investment in Technology and Human Capital 113 RTI 60 External Assessment of Sustainable Development 115 8 BPGC 63 For more information about Sistema Hospitality Assets 66 visit our website: Binnopharm 69 https://sistema.com Other Portfolio Companies 72 Funds 74 Ozon 80 2 SISTEMA Annual Report 2018 sistema.com About the Company Financial Performance Key Asset Results Corporate Governance Social Responsibility 3 PROFILE OF SISTEMA 4 ABOUT INVESTMENT PORTFOLIO 6 CEO’S STATEMENT 8 THE COMPANY KEY EVENTS OF 2018 10 MISSION AND STRATEGY 14 4 SISTEMA Annual Report 2018 sistema.com About the Company Financial Performance Key Asset Results Corporate Governance Social Responsibility 5 1 In accordance with IFRS.
    [Show full text]
  • Pioneer Emerging Markets Equity Fund
    Pioneer Emerging Markets Equity Fund Schedule of Investments | December 31, 2020 Class A PEMEX Class C PEMNX Class Y PEMSX Schedule of Investments | 12/31/20 (unaudited) Shares Value UNAFFILIATED ISSUERS - 99.9% COMMON STOCKS - 99.9% of Net Assets Air Freight & Logistics - 0.2% 28,075 Aramex PJSC $ 33,545 Total Air Freight & Logistics $ 33,545 Auto Components - 1.0% 2,564 Hanon Systems $ 38,194 40,000 Xinyi Glass Holdings Ltd. 111,928 Total Auto Components $ 150,122 Automobiles - 1.4% 56,000 Brilliance China Automotive Holdings Ltd. $ 51,091 1,950 Eicher Motors Ltd. 67,544 1,587(a) Kia Motors Corp. 91,263 Total Automobiles $ 209,898 Banks - 11.8% 75,669(a) Alpha Bank AE $ 88,337 13,968 Banco Bradesco S.A. (A.D.R.) 73,472 10,853 Banco Bradesco S.A., Class Preferen 56,845 12,986 Banco do Brasil S.A. 97,912 74,800 Bank Central Asia Tbk PT 180,226 225,000 China Construction Bank Corp., Class H 171,209 8,254 Commercial International Bank Egypt S.A.E 31,045 136 Credicorp, Ltd. 22,307 52,000 CTBC Financial Holding Co., Ltd. 36,496 10,484 First Abu Dhabi Bank PJSC 36,842 8,506(a) Grupo Financiero Banorte S.A.B de CV, Class O 46,866 1,778(a) HDFC Bank, Ltd. (A.D.R.) 128,478 11,237(a) ICICI Bank, Ltd. (A.D.R.) 166,982 8,689(a) ICICI Bank, Ltd. 63,668 15,258 Itausa - Investimentos Itau S.A. 34,747 19,996(a) National Bank of Greece S.A.
    [Show full text]
  • A Gazprom Como Ferramenta Estratégica No Setor Econômico Russo Nas Relações Com a Europa No Período 1999 – 2012
    CENTRO UNIVERSITÁRIO UNIVATES CENTRO DE GESTÃO ORGANIZACIONAL CURSO DE RELAÇÕES INTERNACIONAIS A GAZPROM COMO FERRAMENTA ESTRATÉGICA NO SETOR ECONÔMICO RUSSO NAS RELAÇÕES COM A EUROPA NO PERÍODO 1999 – 2012 Jéferson Andrei Driemeier Lajeado, novembro de 2015 Jéferson Andrei Driemeier A GAZPROM COMO FERRAMENTA ESTRATÉGICA NO SETOR ECONÔMICO RUSSO NAS RELAÇÕES COM A EUROPA NO PERÍODO 1999 – 2012 Monografia apresentada na disciplina de Trabalho de Conclusão de Curso, do Curso de Relações Internacionais, do Centro Universitário UNIVATES, como parte da exigência para a obtenção do título de Bacharel em Relações Internacionais. Orientador: Prof. Dr. Mateus Dalmáz Lajeado, novembro de 2015 LISTA DE ILUSTRAÇÕES LISTA DE FIGURAS Figura 1 – Participação da Gazprom nas reservas nacionais e internacionais de gás natural e participação na produção global e nacional de gás natural ............................................................................................................... 28 Figura 2 – Rota do projeto Nord Stream................................................................... 32 Figura 3 – Rota do gasoduto Blue Stream................................................................ 33 Figura 4 - Sistema de Abastecimento Unificado de Gás (UGSS)............................. 34 Figura 5 - Falhas no sistema de distribuição por 1.000 quilômetros......................... 35 Figura 6 - Exportações da Gazprom de gás natural para a Europa (bcm)............... 44 Figura 7 - Exportações da Gazprom de gás natural para a Europa por país (bcm)
    [Show full text]
  • Sistema Pjsfc and Subsidiaries
    SISTEMA PJSFC AND SUBSIDIARIES Consolidated Financial Statements for 2019 and Independent Auditor’s Report SISTEMA PJSFC AND SUBSIDIARIES TABLE OF CONTENTS Page STATEMENT OF MANAGEMENT’S RESPONSIBILITIES FOR THE PREPARATION AND APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR 2019 1 INDEPENDENT AUDITOR’S REPORT 2-5 CONSOLIDATED FINANCIAL STATEMENTS FOR 2019: Consolidated statement of profit or loss 6 Consolidated statement of comprehensive income 7 Consolidated statement of financial position 8-9 Consolidated statement of changes in equity 10-11 Consolidated statement of cash flows 12-13 Notes to the consolidated financial statements 1. General 14 2. Basis of preparation 14 3. Significant accounting policies, judgements, estimates and assumptions 14 4. Segment information 18 5. Investigations into former operations in Uzbekistan 20 6. Discontinued operations 21 7. Business combinations 25 8. Capital transactions of subsidiaries 28 9. Revenue 30 10. Impairment of long-lived assets 35 11. Impairment of Financial assets 36 12. Income taxes 36 13. Employee benefits expenses 38 14. Property, plant and equipment 39 15. Investment property 42 16. Goodwill 43 17. Other intangible assets 46 18. Investments in associates and joint ventures 48 19. Other financial assets 53 20. Restricted cash 60 21. Inventories 60 22. Accounts receivable 61 23. Equity 62 24. Accumulated other comprehensive income 63 25. Borrowings 63 26. Lease liabilities and right-of-use assets 66 27. Bank deposits and liabilities 68 28. Other financial liabilities 69 29. Provisions 69 30. Earnings/(losses) per share 70 31. Capital and financial risk management 71 32. Derivative instruments 74 33. Fair values 75 34. Related party transactions 77 35.
    [Show full text]